advertisement
Abstract #108163 Published in IGR 23-4
MicroPulse® Transscleral Laser Therapy (MP-TLT) in Patients with Glaucoma and Ocular Cicatricial Pemphigoid
Logioco C; Delgado MF; Podesta N; Galetto L; Rodriguez-Libarona A; Valvecchia F; Zanutigh VJournal of Glaucoma 2023; 32: e109-e111
A non-comparative retrospective case-series study was performed on 6 patients (12 eyes) with a confirmed diagnosis of ocular cicatricial pemphigoid (OCP), treated with MicroPulse® Transscleral Laser Therapy (MP-TLT), between January 2018 and 2020, with a minimum follow-up of 2 years, in a private ophthalmology practice with offices in Argentina and Colombia. Mean age was 75±6.3 years (66-83yrs). The severity of OCP remained stable 2 years after MP-TLT. Baseline mean IOP was 19.5±5.9 mmHg (13-30 mmHg) and, 24 months after treatment, IOP decreased to a mean of 13.9±1.9 mmHg (10-18 mmHg). The mean IOP reduction was 25.1% (P: 0.002). The mean number of anti-glaucomatous drugs at baseline was 3.1±0.7, decreasing to 0.6±0.7, 2 years after MP-TLT (P<0.001). MP-TLT may be considered as a non-incisional approach to glaucoma care for patients with ocular surface diseases, prospective long term studies are needed.
Centro de Ojos Quilmes. Quilmes, Buenos Aires, Argentina.
Full article